Stuttgart - Delayed Quote EUR

Telix Pharmaceuticals Ltd (T3X.SG)

Compare
14.66
+0.58
+(4.12%)
As of 8:30:19 AM GMT+1. Market Open.
Loading Chart for T3X.SG
DELL
  • Previous Close 14.08
  • Open 14.66
  • Bid 14.09 x --
  • Ask 15.14 x --
  • Day's Range 14.66 - 14.66
  • 52 Week Range 9.75 - 15.69
  • Volume 0
  • Avg. Volume 1,104
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 20, 2025 - Feb 24, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: T3X.SG

View More

Performance Overview: T3X.SG

Trailing total returns as of 1/6/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

T3X.SG
1.88%
S&P/ASX 200 [XJO]
1.20%

1-Year Return

T3X.SG
50.36%
S&P/ASX 200 [XJO]
10.26%

3-Year Return

T3X.SG
50.36%
S&P/ASX 200 [XJO]
12.22%

5-Year Return

T3X.SG
50.36%
S&P/ASX 200 [XJO]
22.59%

Compare To: T3X.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: T3X.SG

View More

Valuation Measures

As of 12/27/2024
  • Market Cap

    4.82B

  • Enterprise Value

    4.82B

  • Trailing P/E

    163.10

  • Forward P/E

    75.19

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    12.56

  • Price/Book (mrq)

    20.10

  • Enterprise Value/Revenue

    12.96

  • Enterprise Value/EBITDA

    113.13

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: T3X.SG

View More